ROLE OF NITRIC OXIDE IN LUNG INFLAMMATION OF COPD PATIENTS - ND
- Conditions
- COPD
- Registration Number
- EUCTR2009-010804-27-IT
- Lead Sponsor
- AZIENDA OSPEDALIERA POLICLINICO DI MODENA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
COPD outpatients in stage II and III of GOLD classification. Patients will be smokers or ex-smokers since at least 6-months, with a similar degree of severity, while on their usual drug therapy.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
No actual use of steroids or antioxidants (i.e. N-acetilcysteine), no evidence of exacerbation in the preceeding 4 weeks.
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method